GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from Sumitomo Chemical (TYO: 4005) the 50% stake it does not already own.

GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

The Chicago-based medical device and technology giant plans to purchase the remaining 50% stake in Nihon Medi-Physics.

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

GE HealthCare Technologies Inc. (GEHC) announced its agreement to acquire the remaining 50% stake in Nihon Medi-Physics Co., Ltd or ...

This week, the FDA issued recommendations for streamlining the clearance process for AI-powered medical devices. The memo announcing this change recognizes that the utilization of AI in devices “is an ...

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, ...

GE HealthCare (GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics ((NMP)) from Sumitomo Chemical. Read ...